Literature DB >> 20981469

How much money can be saved by applying intravenous antibiotics once instead of several times a day?

D Mertz1, H Plagge, S Bassetti, M Battegay, A F Widmer.   

Abstract

BACKGROUND: The preparation, administration and monitoring of intravenous (IV) applications are time consuming and require human resources. We estimated the potential time and cost savings by replacing antibiotics given 3-4 times daily with antibiotics with similar spectrum and efficacy given once daily.
METHODS: The savings of indirect costs were estimated based on the antibiotic consumption data of a two-year period (i.e. 2007 and 2008), a nurse's mean workload per application and the average nurse's salary in Switzerland.
RESULTS: The consumption of IV antibiotics in 2007 and 2008 at the University Hospital of Basel was 29.0 and 32.2 defined daily doses (DDD) per 100 patient days, respectively. Nurses spent an estimated 13,786 h on the application of the estimated 82,715 does of IV antibiotics. A total of 56,404 applications or nursing staff time costs of 338,436 Swiss Francs (CHF; 236,669 <euro>), equal to 16% of the overall costs spent on purchasing antibiotics in the year 2008, may have been saved by switching multiple-dose antibiotics to a hypothetical once-daily antibiotic. Including disposable materials, 21% or 456,884 CHF (319,499 <euro>) could be saved annually (purchase costs not taken into account).
CONCLUSION: We found a potential cost saving of 21% of the purchase costs in a 750-bed institution. Hence, indirect costs should be included in the calculation of the total cost for the application of broad-spectrum IV antibiotics. Switching from a 3-4 times daily application to a once-daily antibiotic should be considered if a once-daily antibiotic is deemed equally effective and has a similar spectrum.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20981469     DOI: 10.1007/s15010-010-0060-x

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

2.  A multi-centre comparison of nursing staff time required for the preparation and administration of liposomal amphotericin B and amphotericin B deoxycholate vs. voriconazole.

Authors:  Elizabeth Flynn; Anne Marciniak; Giuliana Barbabietola; Beryl A Oppenheim; Craig Roberts; Kenneth Barker
Journal:  J Clin Nurs       Date:  2008-11-12       Impact factor: 3.036

3.  Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males.

Authors:  Patrick G Clay; Maqual R Graham; Cameron C Lindsey; Kenneth C Lamp; Collin Freeman; Alan Glaros
Journal:  Am J Geriatr Pharmacother       Date:  2004-09

4.  Cost perspectives for outpatient intravenous antimicrobial therapy.

Authors:  Alan D Tice; Pam A Hoaglund; Barbara Nolet; Peggy S McKinnon; Essy Mozaffari
Journal:  Pharmacotherapy       Date:  2002-02       Impact factor: 4.705

5.  An observational study of intravenous medication errors in the United Kingdom and in Germany.

Authors:  Veronika Wirtz; Katja Taxis; Nick D Barber
Journal:  Pharm World Sci       Date:  2003-06

6.  Comparative costs of ertapenem and piperacillin-tazobactam in the treatment of diabetic foot infections.

Authors:  Alan D Tice; Robin S Turpin; Christopher T Hoey; Benjamin A Lipsky; Jasmanda Wu; Murray A Abramson
Journal:  Am J Health Syst Pharm       Date:  2007-05-15       Impact factor: 2.637

7.  Ertapenem: a new opportunity for outpatient parenteral antimicrobial therapy.

Authors:  Alan D Tice
Journal:  J Antimicrob Chemother       Date:  2004-06       Impact factor: 5.790

8.  Medication errors observed in 36 health care facilities.

Authors:  Kenneth N Barker; Elizabeth A Flynn; Ginette A Pepper; David W Bates; Robert L Mikeal
Journal:  Arch Intern Med       Date:  2002-09-09

9.  Outcomes of early switching from intravenous to oral antibiotics on medical wards.

Authors:  Dominik Mertz; Michael Koller; Patricia Haller; Markus L Lampert; Herbert Plagge; Balthasar Hug; Gian Koch; Manuel Battegay; Ursula Flückiger; Stefano Bassetti
Journal:  J Antimicrob Chemother       Date:  2009-04-28       Impact factor: 5.790

10.  Importance of nondrug costs of intravenous antibiotic therapy.

Authors:  Arthur R H van Zanten; Peter M Engelfriet; Karin van Dillen; Miriam van Veen; Mark J C Nuijten; Kees H Polderman
Journal:  Crit Care       Date:  2003-10-14       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.